| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/30/2008 | CA2250017C Process for encapsulation of caplets in a capsule and solid dosage forms obtainable by such process |
| 09/30/2008 | CA2222811C Stabilized solid dispersions of misoprostol |
| 09/30/2008 | CA2221096C Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate |
| 09/30/2008 | CA2190509C Hepatocyte-selective oil-in-water emulsion |
| 09/30/2008 | CA1341580C Tissue-type plasminogen activator mutants |
| 09/25/2008 | WO2008116135A2 Topical formulations having enhanced bioavailability |
| 09/25/2008 | WO2008116004A2 Transdermal patch and method for delivery of vitamin b12 |
| 09/25/2008 | WO2008115979A2 Meltable binder for melt granulation and/or pelletization |
| 09/25/2008 | WO2008115961A2 Sustained-release composition |
| 09/25/2008 | WO2008115799A1 Novel gene delivery vectors for human mesenchymal stem cells |
| 09/25/2008 | WO2008115599A1 Apparatus and method for transdermal delivery of a 5-hydroxytrytamine antagonist |
| 09/25/2008 | WO2008115586A1 Apparatus and method for transdermal delivery of a triptan agonist |
| 09/25/2008 | WO2008115371A2 Amorphous drug transdermal systems, manufacturing methods, and stabilization |
| 09/25/2008 | WO2008115179A1 Pull apart multiple fragrance and cosmetic sampler |
| 09/25/2008 | WO2008114889A1 Oral vaccine |
| 09/25/2008 | WO2008114861A1 Alcohol-containing quinolone pharmaceutical composition |
| 09/25/2008 | WO2008114859A1 Pharmaceutical composition containing pyrazole derivative |
| 09/25/2008 | WO2008114800A2 Solid preparation comprising 2- [ [6- [ (3r) -3-amino-1-piperidinyl] -3, 4-dihydro-3-methyl-2, 4-dioxo-1 (2h) -pyrimidinyl] methyl] -4-fluorobenzonitrile |
| 09/25/2008 | WO2008114787A1 Antiviral agent |
| 09/25/2008 | WO2008114679A1 Bone metabolism ameliorating agent |
| 09/25/2008 | WO2008114553A1 Allergen inactivator |
| 09/25/2008 | WO2008114516A1 Liposome and immunostimulating composition comprising the same |
| 09/25/2008 | WO2008114513A1 Prophylactic and/or therapeutic agent for cardiac infarction |
| 09/25/2008 | WO2008114280A1 Novel reduced dose pharmaceutical compositions of fexofenadine and pseudoephedrine |
| 09/25/2008 | WO2008114276A1 Novel oral controlled release composition of carvedilol |
| 09/25/2008 | WO2008114274A1 Proliposomal and liposomal compositions |
| 09/25/2008 | WO2008114143A1 Extended release formulations of macrolide antibiotic |
| 09/25/2008 | WO2008114052A1 Process for making crystals |
| 09/25/2008 | WO2008113803A1 Hot-melt micropellets |
| 09/25/2008 | WO2008113421A1 New pharmaceutical compositions for lipolysis and method for the production thereof |
| 09/25/2008 | WO2008113390A1 Stereo photo hydrofel, a process of making said stereo photo hydrogel, polymers for use in making such hydrogel and a pharmaceutical comprising said polymers |
| 09/25/2008 | WO2008113368A1 A gelatin capsule with extra cap for combined therapies |
| 09/25/2008 | WO2008113358A1 Liquid formulations of salts of 4-[2-(4-methylphenylsulfanyl)phenyl]piperidine |
| 09/25/2008 | WO2008113183A1 Use of francisella tularensis for prevention and treatment of allergic airway disorders |
| 09/25/2008 | WO2008113177A1 Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof |
| 09/25/2008 | WO2008113115A1 Body fluid supplement composition and uses thereof |
| 09/25/2008 | WO2008113114A1 Body fluid supplement compositions and their use in subjects undergoing medical treatment |
| 09/25/2008 | WO2008098195A3 Film comprising nitroglycerin |
| 09/25/2008 | WO2008092219A3 Pharmaceutical composition comprising tramadol and ketoprofen |
| 09/25/2008 | WO2008086971A3 β-LACTAM-CONTAINING FORMULATIONS HAVING INCREASED STABILITY IN AQUEOUS SOLUTION |
| 09/25/2008 | WO2008081175A3 Method of producing a composition from an oleogel and an aqueous gel and the composition |
| 09/25/2008 | WO2008079260A3 Disintegration promoters in solid dose wet granulation formulations |
| 09/25/2008 | WO2008077110A3 Ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers |
| 09/25/2008 | WO2008070264A3 Nasal spray composition and method for treating rhinitis, sinusitis or both |
| 09/25/2008 | WO2008067399A3 Controlled-release multi-layer formulation of piperazine-piperidine antagonists and agonists of the 5-th1a receptor having enhanced intestinal dissolution |
| 09/25/2008 | WO2008065369A3 A bleomycin preparation for use against skin tumours |
| 09/25/2008 | WO2008063541A3 Variable flow infusion pumps system |
| 09/25/2008 | WO2008062475A3 Pharmaceutical compositions of ursodiol |
| 09/25/2008 | WO2008044963A3 Magnetic carrier and medical preparation for controllable delivery and release of active substances, a method of production and method of treatment using thereof |
| 09/25/2008 | WO2008031631A3 Oral modified release formulations |
| 09/25/2008 | WO2008028602A3 Chewing gum preparations comprising physiological agents |
| 09/25/2008 | WO2008024753A3 Lipid-derived nanoparticles for brain-targeted drug delivery |
| 09/25/2008 | WO2008018932A3 Method and use of nano-scale devices for reduction of tissue injury in ischemic and reperfusion injury |
| 09/25/2008 | WO2007149310A3 Multiphasic biofunctional nano-components and methods for use thereof |
| 09/25/2008 | WO2007143652A3 Chewable soft gelatin capsules |
| 09/25/2008 | WO2007113207A3 Coated formulations |
| 09/25/2008 | WO2007098254A3 Nanoparticles for immunotherapy |
| 09/25/2008 | WO2007095296A3 Fluid delivery apparatus with vial fill |
| 09/25/2008 | WO2007087431A3 Sublingual fentanyl spray |
| 09/25/2008 | WO2007034219A3 Modifying leukocyte function |
| 09/25/2008 | WO2007026124A3 Transdermal delivery means of a diuretic agent and/or cardiac glycoside agent |
| 09/25/2008 | WO2007025767A3 Nanoparticulate inclusion and charge complex for pharmaceutical formulations |
| 09/25/2008 | US20080234621 Methods and Apparatus for Creating Particle Derivatives of HDL with Reduced Lipid Content |
| 09/25/2008 | US20080234483 Fasudil-Containing Preparation and Method of Improving Stability Thereof |
| 09/25/2008 | US20080234353 Stable tablets of ramipril, optionally in combination with a diuretic, containing 50-95% w/w of calcium sulphate dihydrate and 0.1-5.0% W/w of sodium bicarbonate |
| 09/25/2008 | US20080234352 Controlled release solid dispersions |
| 09/25/2008 | US20080234343 For oral administration, a transparent liquid mixture of an oily base, a surfactant, polar solvent, and an amount of a drug that is not very soluble in the solvent that exceeds its solubility in the solvent; dugs include 1,2,3,4-tetrahydro-1-benzazocine-5-carboxamide derivatives |
| 09/25/2008 | US20080234325 Novel Methods Using Pyridine Derivatives |
| 09/25/2008 | US20080234291 Apolipo-protein B (apoB) secretion and microsomal triglyceride transfer protein (MTP) inhibiting properties; hyperlipidemia, obesity, or type II diabetes; solubility, taste modifying agent and an antioxidant |
| 09/25/2008 | US20080234247 Heterocyclic analgesic compounds and methods of use thereof |
| 09/25/2008 | US20080234200 Saline formulation of a glucose-regulating peptide (amylin, synthtic hormone pramlintide, glucon like peptide-1, extendins), water, sodium chloride and a buffering agent; identical ph and osmolarity for both transmucosal glucose regulating peptide and saline water; antidiabetic, antiobesity agent |
| 09/25/2008 | US20080234179 Orally dosed pharmaceutical compositions comprising a delivery agent in micronized form |
| 09/25/2008 | US20080233651 Method and medicament for inhibiting the expression of a given gene |
| 09/25/2008 | US20080233201 Method for Preparing Calibrated Biodegradable Microspheres |
| 09/25/2008 | US20080233200 Enhancing absorption of bioactive agent through epithelial cells using nanoparticles with a shell of chitosan, said bioactive agent and a core of polyglutamic acid; bioavailability of biodrugs, peptides, hormones, insulin, Alzheimer's drugs for oral administration |
| 09/25/2008 | US20080233199 Forming a coacervate of an active agent, a biocompatible polymer and a solvent; combining with a quench liquid forming microparticles containing the active agent; adding a second coacervation agent |
| 09/25/2008 | US20080233198 Administering microcapsules containing a peptide and copolymer incorporating triethyl citrate, tributyl citrate or acetyl tributyl citrate; reducing initial release, providing steady release over time |
| 09/25/2008 | US20080233197 Pharmaceutical compositions |
| 09/25/2008 | US20080233196 With sterile sodium bicarbonate, soluble in water, high stability with time. |
| 09/25/2008 | US20080233195 Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage growth |
| 09/25/2008 | US20080233194 Stabilized ; dispersion in dispersion microstructure; administering to lungs |
| 09/25/2008 | US20080233193 Oral antimicrobial pharmaceutical compositions |
| 09/25/2008 | US20080233192 Compressed mixture of a diluent and granules of a very slightly soluble drug; a core of saccharose beads and a coating layer of a very slightly soluble drug and a film-forming substance of high-molecular weight |
| 09/25/2008 | US20080233191 Use of ranolazine for elevated brain-type natriuretic peptide |
| 09/25/2008 | US20080233190 Segmented Pharmaceutical Dosage Forms |
| 09/25/2008 | US20080233189 Contiguous with compositionally substantially identical unitary segments that contain drugs; accurate means of dosing with a compressed, segmented pharmaceutical tablet |
| 09/25/2008 | US20080233188 [5-(4-bromo-phenyl)-6-[2-(5-bromo-pyrimidin-2-yloxy)-ethoxy]-pyrimidin-4-yl]-amide, a disintegrant, a surfactant, and a lubricant; endothelin receptor inhibitor |
| 09/25/2008 | US20080233187 Method of Production of Fine-Crystalline Mixture Containing Non-Steroid Anti-Inflammatory Drug, Fine-Crystalline Mixture Obtainable by this Method and Solid Pharmaceutical Composition Containing this Mixture |
| 09/25/2008 | US20080233186 Dietary composition of L-Arginine alpha amino n-Butryate; enhancing lean body mass and exercise performance |
| 09/25/2008 | US20080233185 Using dimethyl fumarate and/or diethyl fumarate, calcium alkyl fumarate, calcium methyl fumarate and/or calcium ethyl fumarate, zinc methyl fumarate and/or zinc ethyl fumarate, methyl hydrogen fumarate and/or ethyl hydrogen fumarate; sclerodermia, osteochondritis syphilitica (Wegener's disease) |
| 09/25/2008 | US20080233184 Combination enzyme products |
| 09/25/2008 | US20080233183 Liposomal concentrate of a phospholipid, lipophilic bioactive agent, a solubilizer, a carrier permeation enhancer; analgesics, anti-inflammatory agents, anthelmintics, anti-arrhythmic agents, anti-bacterial agents, anti-viral agents, anti-coagulants, anti-depressants, anti-diabetics |
| 09/25/2008 | US20080233182 Organic compounds |
| 09/25/2008 | US20080233181 Nanoparticle adjuvants for sub-unit vaccines |
| 09/25/2008 | US20080233179 Transdermal composition having enhanced color stability |
| 09/25/2008 | US20080233178 Opioid antagonist dispersed in a polymeric matrix; releasing opioid antagonist if the transdermal delivery device is chewed, soaked, punctured, torn, or subjected to any other treatment which disrupts the integrity of the microspheres |
| 09/25/2008 | US20080233177 Applying individually dosed portions of a flowable, active substance-containing preparation onto a pressure-sensitive adhesive laye, applying an impermeable, backing layer; cutting and punching from the composite laminate |
| 09/25/2008 | US20080233174 Polymer and an active ingredient; polyethylene oxide, polyvinyl acetate, polymethacrylate, polyethylene glycols, polypropylene glycol, polyethylene/polypropylene glycol copolymer or polyvinylpyrolindone and dextromethorphan, acetaminophen, or simethicone |
| 09/25/2008 | US20080233173 Inserting an implant into an ocular site; an active agent and a polymer carrier; releasing the active agent from the implant |
| 09/25/2008 | US20080233172 Inserting an implant into an ocular site; an active agent and a polymer carrier; releasing the active agent from the implant |